A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind

Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.

Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.

  1. Home
  2. Subjects
  3. National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases
Q&A: Anthony Fauci Describes an Experimental Ebola Treatment
Q&A: Anthony Fauci Describes an Experimental Ebola Treatment
Shawna Williams | Aug 14, 2018
The monoclonal antibody, known as mAb114, is likely to be used in the current Ebola outbreak in DRC.
Pregnant Women Absent from Zika Vaccine Trials
Pregnant Women Absent from Zika Vaccine Trials
Aggie Mika | Aug 14, 2017
Some vaccine developers are taking steps to include them, in line with bioethicists' urging, but it will likely take years before any expectant mothers are enrolled.